AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2018
Mar 2, 2018
29875_dirs_2018-03-02_6a72221f-315f-4cdf-ac3d-f04a8797a703.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-02-28
Reporting Person: Bisaccia Lisa (EVP and Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | A | 2923 | $67.73 | Acquired | 18479 | Direct |
| 2018-02-28 | Common Stock | F | 885 | $67.73 | Disposed | 17594 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 23084.0004 | Direct |
| ESOP Common Stock | 592.536 | Indirect |
| Stock Unit | 30522.1848 | Direct |
Footnotes
F1: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3